Pfizer and German mRNA partner BioNTech have grabbed an FDA fast track label as they look to start a late-stage, 30,000-patient COVID-19 vaccine test before the month is out. As Moderna has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results